Table 4.
Body weight, diet consumption, plasma lipid profile and inflammatory biomarkers observed in the supplemented groups
| CON | FIS | ALG | ECH | P1 | |
|---|---|---|---|---|---|
| Initial weight (g) |
26.9 ± 1.3 |
26.8 ± 0.6 |
27.3 ± 0.1 |
27.8 ± 0.8 |
0.670 |
| Final weight (g) |
28.9 ± 2.0 |
28.3 ± 0.6 |
29.8 ± 1.4 |
28.8 ± 0.5 |
0.731 |
| Weight gain (g) |
2.0 ± 0.7 |
1.5 ± 0.0 |
2.5 ± 1.3 |
1.1 ± 1.3 |
0.542 |
| Diet consumption (g/d/mouse) |
2.3 ± 0.2 |
2.3 ± 0.1 |
2.3 ± 0.1 |
2.4 ± 0.3 |
0.886 |
| Cholesterol (mg/100 mL) |
371.7 ± 37.4a |
349.8 ± 37.2ab |
350.2 ± 56.3ab |
312.9 ± 40.2b |
0.040 |
| LDL (mg/100 mL) |
244.3 ± 32.2 |
240.4 ± 34.2 |
227.6 ± 50.4 |
199.3 ± 31.4 |
0.054 |
| HDL (mg/100 mL) |
95.9 ± 8.8 |
82.7 ± 13.7 |
95.0 ± 8.4 |
92.0 ± 13.7 |
0.050 |
| VLDL (mg/100 mL) |
29.7 ± 4.6a |
26.7 ± 5.1a |
27.6 ± 9.7 a |
21.6 ± 3.5b |
0.036 |
| Triacylglicerol (mg/100 mL) |
149.0 ± 23.6a |
133.6 ± 25.4ab |
115.8 ± 34.2b |
109.1 ± 17.5 b |
0.008 |
| CRP (ng/mL) |
121.6 ± 5.5 |
118.9 ± 6.7 |
118.0 ± 9.6 |
124.6 ± 8.6 |
0.232 |
| IL-6 (pg/mL) |
11.4 ± 2.3 |
10.6 ± 2.0 |
10.1 ± 1.9 |
11.2 ± 2.0 |
0.457 |
| VCAM (pg/mL) |
1.7 ± 0.4 |
1.7 ± 0.3 |
1.6 ± 0.5 |
1.3 ± 0.2 |
0.059 |
| ICAM (ng/mL) |
39.3 ± 6.7 |
36.9 ± 3.8 |
39.2 ± 4.4 |
35.4 ± 3.4 |
0.188 |
| ADIPONECTIN (pg/mL) | 13.9 ± 8.3 | 14.4 ± 6.0 | 11.5 ± 3.7 | 14.3 ± 9.3 | 0.805 |
1 Probability value obtained by ANOVA. Values followed by the same letter are not significantly different at the 0.05; a,b: p<0.05(n = 10/group).